Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

0.2970 -0.0070 (-2.30%)
Streaming Delayed Price Updated: 10:36 AM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,543
Open 0.2940
Bid (Size) 0.2900 (86)
Ask (Size) 0.3030 (134)
Prev. Close 0.3040
Today's Range 0.2850 - 0.3092
52wk Range 0.1970 - 2.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-24.4%
-24.4%
1 Month
-10.5%
-10.5%
3 Month
-24.4%
-24.4%
6 Month
+31.0%
+31.0%
1 Year
-83.5%
-83.5%

More News

Read More
Curious about the most active stocks on Monday?
Via Chartmill
Bulls Turn to Pennies STSS, ADTX, CSDX, SPRC, CBDW, YGTFF During Market Uncertainty – Small-Cap Stocks Poised for Big Moves
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
SciSparc Shares Are Soaring Monday: What's Going On?
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Top movers in Monday's pre-market session
Via Chartmill
SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Addiction Psychedelic Combination Treatment in South Korea
From SciSparc Ltd
Via GlobeNewswire
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
From Clearmind Medicine Inc.
Via GlobeNewswire
SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers
From SciSparc Ltd
Via GlobeNewswire
SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles
From SciSparc Ltd
Via GlobeNewswire
SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology
From SciSparc Ltd
Via GlobeNewswire
SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
From SciSparc Ltd
Via GlobeNewswire
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
From SciSparc Ltd
Via GlobeNewswire
SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles
From SciSparc Ltd
Via GlobeNewswire
SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results
From SciSparc Ltd
Via GlobeNewswire
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet
Via Benzinga
S&P Jumps 1%; Regional Health Properties Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?
Via Benzinga
Exposures Product Safety
US Stocks Open Higher; Dow Jumps Over 200 Points
Via Benzinga
Topics Stocks
Exposures US Equities
SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
From SciSparc Ltd
Via GlobeNewswire
SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder
From SciSparc Ltd
Via GlobeNewswire
S&P 500 Edges Lower, SciSparc Shares Surge
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Gains 50 Points, SEALSQ Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Dips Over 100 Points, US Initial Jobless Claims Fall
Via Benzinga
SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment
Via Benzinga

Frequently Asked Questions

Is SciSparc Ltd. - Ordinary Shares publicly traded?
Yes, SciSparc Ltd. - Ordinary Shares is publicly traded.
What exchange does SciSparc Ltd. - Ordinary Shares trade on?
SciSparc Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for SciSparc Ltd. - Ordinary Shares?
The ticker symbol for SciSparc Ltd. - Ordinary Shares is SPRC on the Nasdaq Stock Market
What is the current price of SciSparc Ltd. - Ordinary Shares?
The current price of SciSparc Ltd. - Ordinary Shares is 0.2970
When was SciSparc Ltd. - Ordinary Shares last traded?
The last trade of SciSparc Ltd. - Ordinary Shares was at 04/03/25 10:36 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.